Cosmos Health Inc.

As of June 30, 2026, Cosmos Health Inc carries a market capitalization of 13.11M, placing it among publicly traded companies globally. Its enterprise value stands at 25.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cosmos Health Inc's next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2026, Cosmos Health Inc has 80.67M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.11, and the price-to-book ratio stands at 0.72.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.39 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 25.48M versus a market cap of 13.11M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Cosmos Health Inc maintains a current ratio of 1.05, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 77.27, indicating elevated leverage, while an interest coverage ratio of -4.58 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Cosmos Health Inc posted a negative return on equity (ROE) of -104.00, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -39.56, reflecting losses generated across the asset base. The company generates approximately 404,601.82 in revenue per employee across its workforce of 159.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 13.74 indicates how many times Cosmos Health Inc sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Cosmos Health Inc's stock has declined approximately 73.88% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.27.

Over the twelve months ended June 30, 2026, Cosmos Health Inc generated 64.53M in revenue and converted that into -21.35M in net income, yielding earnings per share of -0.50. EBITDA reached -14.83M, while operating income came in at -15.91M.

As of June 30, 2026, Cosmos Health Inc holds 1.61M in cash and equivalents against 13.98M in total debt, resulting in a net debt position of 11.85M. Total book value stands at 18.10M, with working capital of 1.60M providing operational flexibility.

Cosmos Health Inc produced -8.61M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -83,580.65 in capital expenditures, free cash flow totaled -8.69M - equivalent to -0.20 per share.

Over the twelve months ended June 30, 2026, Cosmos Health Inc posted a gross margin of 10.27, reflecting its pricing power and cost economics. The operating margin of -24.65 and net profit margin of -33.08 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -126.09: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -93.66, meaning Cosmos Health Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Cosmos Health Inc's most recent stock split took place on December 16, 2022 with a 25:1 split ratio.

As of June 30, 2026, Cosmos Health Inc has an Altman Z-Score of -3.14, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.